Published in Int J Cardiol on September 01, 1991
Hypokalemia and sudden cardiac death. Exp Clin Cardiol (2010) 0.98
pre-operative serum potassium levels and peri-operative outcomes in patients undergoing cardiac surgery. Indian J Clin Biochem (2004) 0.85
Adrenal adenoma presenting with ventricular fibrillation. Tex Heart Inst J (2005) 0.81
Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study. Mayo Clin Proc (2016) 0.81
Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts. Biomed Rep (2016) 0.80
Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care (2016) 0.75
The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes. Medicine (Baltimore) (2016) 0.75
Acute coronary syndromes. Challenging accepted post-MI serum potassium targets. Nat Rev Cardiol (2012) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation. Blood (1997) 2.35
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med (1995) 1.96
Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol (1977) 1.78
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70
Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med (1975) 1.62
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med (1976) 1.58
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol (1998) 1.56
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
Diabetes, prediabetes and uricaemia. Diabetologia (1976) 1.29
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis (1971) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chronic Dis (1973) 1.22
Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med (1971) 1.22
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med (1976) 1.13
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation (1999) 1.13
The epidemiology of coronary heart disease in the ethnically and culturally diverse population of Israel. A review. Isr J Med Sci (1982) 1.13
High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke (1997) 1.12
Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin. Br J Prev Soc Med (1974) 1.12
Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J (1992) 1.11
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables. Isr J Med Sci (1974) 1.11
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J (1972) 1.06
Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation (2001) 1.05
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med (1993) 1.04
Antihypertensive therapy and the risk of malignancies. Eur Heart J (2001) 1.04
Characteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. Isr J Med Sci (1975) 1.03
Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J (1997) 1.03
Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med (1992) 1.02
Ferromagnetism in the Mott insulator Ba2NaOsO6. Phys Rev Lett (2007) 1.00
Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol (1983) 0.99
Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience. J Chronic Dis (1973) 0.99
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99
Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chronic Dis (1980) 0.98
Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. The ARIC Investigators. Stroke (1994) 0.98
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol (1996) 0.97
Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia (1977) 0.97
Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis. Am Heart J (1993) 0.97
Enhanced risk of coronary heart disease mortality in lean hypertensive men. Hypertension (1987) 0.97
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. Arterioscler Thromb Vasc Biol (1996) 0.96
Are lean smokers at increased risk of lung cancer? The Israel Civil Servant Cancer Study. Arch Intern Med (1996) 0.95
Adult-onset diabetes among Arabs and Jews in Israel: a population-based study. Diabet Med (2012) 0.94
High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Arch Intern Med (2000) 0.94
Clinical myocardial infarction over a five-year period--III. A multivariate analysis of incidence, the Israel ischemic heart disease study. J Chronic Dis (1975) 0.94
Angina pectoris among 10,000 men. 5 year incidence and univariate analysis. Am J Med (1973) 0.92
Association between metabolic syndrome, diabetes mellitus and prostate cancer risk. Prostate Cancer Prostatic Dis (2013) 0.91
Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review. J Heart Valve Dis (2001) 0.91
Coronary heart disease: genetic aspects. Circulation (1983) 0.90
Long-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction. Data from the SPRINT Registry. Eur Heart J (1996) 0.90
Life-threatening "vagal reaction" to emotional stimuli. Isr J Med Sci (1977) 0.89
Repair of ventricular septal defect and left ventricular aneurysm following myocardial infarction. Thorax (1971) 0.89
Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation (1998) 0.89
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1995) 0.89
Intermittent claudication in 8343 men and 21-year specific mortality follow-up. Ann Epidemiol (1997) 0.88
Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol (1994) 0.88
Association between blood-pressure and peptic-ulcer incidece. Lancet (1970) 0.87
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia. J Am Coll Cardiol (1990) 0.87
Blood pressure in Ethiopian immigrants in Israel: comparison with resident Israelis. J Hypertens Suppl (1989) 0.87
Prolapse of the mitral valve in Klippel-Feil syndrome. Chest (1981) 0.86
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study. Am J Med (2001) 0.86
Influence of physical work on high density lipoprotein cholesterol: implications for the risk of coronary heart disease. Int J Sports Med (1994) 0.85
Antihypertensive therapy in diabetic hypertensive patients. Am J Hypertens (2001) 0.85
Blood groups and serum cholesterol among 10,000 adult males. Atherosclerosis (1972) 0.85
Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group. Am J Cardiol (1993) 0.85
Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group. Stroke (1993) 0.84
A right atrial mass in the presence of a permanent pacemaker electrode in a patient with polycythemia vera. Pacing Clin Electrophysiol (1991) 0.84
Hypertension in middle-aged men. Associated factors and mortality experience. Isr J Med Sci (1983) 0.84
The importance of biopsychosocial factors in the development of duodenal ulcer in a cohort of middle-aged men. Am J Epidemiol (1992) 0.84
The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Israeli Thrombolytic Survey Group. Am J Med (1996) 0.84
Nutritional recommendations for preventing coronary heart disease in women: evidence concerning whole foods and supplements. Nutr Metab Cardiovasc Dis (2010) 0.84
High density lipoprotein cholesterol: prognosis after myocardial infarction. The Israeli Ischemic Heart Disease Study. Int J Epidemiol (1986) 0.84
Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study. Am J Cardiol (1990) 0.84
Selectively increased risk of cancer in men with coronary heart disease. Am J Cardiol (2001) 0.83
Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol (1999) 0.83
Short- and long-term prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med (1994) 0.83
Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: variation by country beyond predictive profile. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol (1993) 0.82
Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national study. Am Heart J (2001) 0.82
Prevalence of diabetes mellitus in Ethiopian immigrants. Isr J Med Sci (1991) 0.82